Author

L. Jeanson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Djiane· 1 shared C. Gongora· 1 shared C. VINCENT-FABERT· 1 shared D. Kantar· 1 shared D. Tosi· 1 shared J. FEUILLARD· 1 shared L. Berhelin· 1 shared L. Heron-Milhavet· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Djiane

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

B-cell specific expression of the murine Myd88L252P mutation correlates with the establishment of an immunosuppressive microenvironnement in Waldenstrom macroglobulinemia lymphoplasmacytic lymphoma

Q. LEMASSON, O. TETEAU, M. CHABAUD, L. JEANSON, J. FEUILLARD, C. VINCENT-FABERT

This study shows that B-cell specific Myd88L252P mutation in mice leads to an immunosuppressive microenvironment in Waldenstrom macroglobulinemia, promoting T-cell exhaustion and disease progression.

bioRxiv · Sep 28, 2023 · PreprintImmunology

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in colon cancer cells

V. Slaninova, L. Heron-Milhavet, M. Robin, L. Jeanson, D. Kantar, D. Tosi, L. Berhelin, C. Gongora, A. Djiane

The paper shows that TAZ/WWTR1 promotes oxaliplatin sensitivity in colon cancer cells through nuclear accumulation, independent of P73 but requiring DNA damage and P53 activity.

bioRxiv · Mar 17, 2023 · PreprintCancer Biology